期刊文献+

MicroRNA在肿瘤中的作用及机制 被引量:5

The roles and mechanisms of microRNAs in tumor
下载PDF
导出
摘要 肿瘤的发生和发展是一个多因素、多步骤的过程。越来越多的证据表明,肿瘤的发生发展与表观遗传学机制所致的癌基因激活和抑癌基因失活有关。表观遗传学尤其是miRNA调控异常导致的癌基因和抑癌基因表达异常研究越来越深入,miRNA调控异常介导的肿瘤放化疗抗拒是目前成功治疗大多数肿瘤的主要阻碍。虽然表观遗传学中miRNA研究越来越多,但是miRNA介导放化疗抗拒的相关文献较少,本综述希望结合目前miRNA在肿瘤中的作用以及其放化疗耐受的机制作进一步的探讨,深入了解miRNA在肿瘤中的作用能有望为我们治疗肿瘤提供新思路。 The tumorigenesis and progression of cancers are a multi-step and multi-factor process. More and more evidence has suggested that several factors, including gene regulatory mechanisms and epigenetic regulations, are involved in carcinogenesis and progression. Recent studies have focused on the epigenetic changes especially ofmiRNA which can lead to dysfunctions of oncogenes and tumor suppressor genes. However, the underlying mechanism of miRNAs on chemo- and radio- resistance of tumors remains unclear and the related researches are very few. This review discusses new insights into the role of miRNAs in regulating genes or proteins and explains how miRNAs influence treatment efficacy in cancer chemotherapy and radiotherapy through miRNAs regulation.
出处 《分子诊断与治疗杂志》 2013年第2期111-116,共6页 Journal of Molecular Diagnostics and Therapy
基金 国家自然科学基金(81071837) 广东省自然科学基金(9251008901000005) 广东省科技计划(2010B050700016)
关键词 MICRORNA 肿瘤 放化疗抗拒 信号转导 MicroRNA Tumor Chemoradioresistant signal transduction
  • 相关文献

参考文献1

二级参考文献37

  • 1Valencia CA, Cotten SW and Liu R. Cleavage of BNIP-2 and BNIP-XL by caspases. Biochem Biophys Res Commun 2007, 364: 495-501.
  • 2Longley DB, Allen WL and Johnston PG. Drug resistance, predictive markers and pharmacogenomics in colorectal cancer, t3iochim Biophys Acta 2006, 1766: 184-196.
  • 3Fojo T. Multiple paths to a drug resistance phenotype; mutations, translocations, deletions and amplification of coding genes or promoter regions, epigenetic changes and rniRNAs. Drug Resist Update 2007, 10: 59-67.
  • 4Allen WL, Coyle VM and Johnston PG. Predicting the outcome of chemotherapy for colorectal cancer. Curr Opin Pharmacol 2006, 6: 332-336.
  • 5Blower PE, Chung JH, Verducci JS, Lin S, Park JK, Dai Z and Liu CG, et al. MiRNAs modulate the chemosensitivity of tumor ceils. Mol Cancer Ther 2008. 7: 1-9.
  • 6Calin GA and Croce CM. MiRNA signatures in human cancers. Nat Rev Cancer 2006, 6: 857-866.
  • 7Bartel DP. MiRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116: 281-297.
  • 8He L, Thomson JM, Hemann MT, Hemando-Monge E, Mu D, Goodson S and Powers S, et al. A miRNA polycistron as a potential human oncogene. Nature 2005, 435: 828-833.
  • 9Chen CZ, Li L, Lodish HF and Bartel DP. MiRNAs modulate hematopoietic lineage differentiation. Science 2004, 303: 83-86.
  • 10Chan JA, Krichevsky AM and Kosik KS. MiRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 2005, 65: 6029-6033.

共引文献17

同被引文献28

  • 1莫莉,唐发清.细胞周期素CyclinD1异常与肿瘤[J].实用预防医学,2006,13(5):1386-1388. 被引量:1
  • 2Wang A G , Moon H B ,Lee M R, et al. Gender-dependent hepatic alterations in H-rasl2V transgenic mice[ J]. Journal of Hepatology, 2005,43 (5) : 836-844.
  • 3Hosui A, Kimura A, Yamaji D, et al. Loss of STAT5 causes liver fibrosis and cancer development through increased TGF - 13 and STAT3 activation [ J]. J Exp Med, 2009, 206 (4): 819-831.
  • 4Braconi C. microRNA - 29 can regulate expression of the longnon-coding RNA gene MEG3 in hepatocellular cancer [ J]. Oncogene, 2011, 30 (47): 4750-4756.
  • 5Rajput S, Kumar B N, Dey K K et al. Molecular targeting of Akt by thymoquinone promotes G1 rest through translation inhibition of cyclin-D1 and induces apoptosis in breast cancer cells [ J]. Life Sci, 2013,93(21 ) :783-790.
  • 6Arber N, Gammon M D, Hibshoosh H, et al. Overexpression of cyclinDl occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach [ J ]. Hum Pathol, 1999,30 ( 9 ) : 1087- 1092.
  • 7KimY M, Geiger T R, Eqan D I et al. The HTLV - 1 tax protein cooperates with phosphorylated CREB, TORC2 and p300 to activate CRE-dependent cyclin DI transcription [ J ]. Oncogene, 2010,29(14) :2142-2152.
  • 8Zhang H S, Yan B, Li X B et al. PAX2 Protein Induces Expression of Cyclin D1 through Activating AP - 1 Protein and Promotes Proliferation of Colon Cancer Cells [ J]. J Biol Chem, 2012,287(53) :44164-44172.
  • 9Nagata D. E, Suzuki H, Nishimatsu H, et al. Transcriptional activation of the cyclin D1 gene is mediated by multiple cis- elements, including SP1 sites and a cAMP-responsive element in vascular endothelial cells [ J ]. J Biol Chore, 2001 , 276 ( 1 ) : 662-669.
  • 10Susana, Garcia-Silva , Ana Aranda. The thyroid hormone receptor is a suppressor of ras-mediated transcription, proliferation and transformation [ J ]. Mol Cell Biol, 2004,24 (17) :7514-7523.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部